Immunotherapy in GU Cancers

Publication
Article
Special ReportsImmunotherapy (Issue 5)
Volume 5
Issue 1

Mark A. Rubin, MD, director, Institute for Precision Medicine, Weill Cornell Medical College, discusses immunotherapy in the field of genitourinary cancers.

Mark A. Rubin, MD, director, Institute for Precision Medicine, Weill Cornell Medical College, discusses immunotherapy in the field of genitourinary cancers.

<<<

View the entire Special Report on Immunotherapy

Related Videos
Related Content